FREE Case Review (866) 588-0600

Arkansas Mounjaro Stomach Paralysis Lawsuit (Latest Updates)

Awards & recognition
Collen Clark Published by Collen Clark
Free Confidential Mounjaro Stomach Paralysis Lawsuit Review
If you or a loved one suffered from stomach paralysis or another injury after taking Mounjaro or another weight loss medication, you should contact our lawyers today.

You may be entitled to compensation by filing a Mounjaro Stomach Paralysis Lawsuit and our lawyers can help. Please click the button below for a Free Confidential Case Evaluation or call our law firm today by dialing (866) 588-0600.

Start My Free Case Review

Quick Summary

  • Grasping the Arkansas Mounjaro stomach paralysis lawsuit is vital to understanding the legal actions against Eli Lilly for not sufficiently warning about the risk of gastroparesis associated with Mounjaro. The FDA has received adverse event reports linked to Mounjaro, raising safety concerns that have led to individuals filing lawsuits.
  • This article offers essential insights into the legal action against Eli Lilly for not warning about Mounjaro’s gastroparesis risk, detailing plaintiffs’ struggles, the drug’s impact, and your rights if affected.
  • If you or someone you know has been affected by complications from Mounjaro, Schmidt & Clark, LLP, is here to assist you. Renowned for our proficiency in plaintiff representation, our main objective is to ensure you obtain the justice and compensation you rightfully deserve.

How S&C Can Help With Your Claim?

S&C can help with your claim by providing unparalleled legal assistance for those affected by Mounjaro-induced gastroparesis. Our firm understands the complexities of pharmaceutical litigation and the profound impact these cases have on our clients’ lives.

We can help you with your Mounjaro-induced gastroparesis claim by offering expert legal representation, thorough case evaluations, and strong evidence presentation:

  • Expert legal representation
  • Thorough case evaluations
  • Strong evidence presentation

Mounjaro Stomach Paralysis Lawsuit

A group of Arkansas residents located centrally in the United States has leveled accusations against the pharmaceutical titan Eli Lilly.

They allege that the company did not sufficiently warn about the severe gastrointestinal side effects of their diabetes medication – Mounjaro – which causes users to experience gastroparesis or stomach paralysis. These adverse events include severe stomach problems and other rare but serious medical conditions.

The lawsuit in Arkansas is part of a broader pattern of legal actions against Nordisk and Eli Lilly. Similar to the recent Ozempic lawsuit, these cases involve claims that the companies did not fully disclose the risks associated with their products. Plaintiffs have reported severe vomiting as one of the adverse events linked to Mounjaro.

These cases expose an unsettling pattern of pharmaceutical behemoths valuing profits over patient safety, leaving people to deal with the damaging aftermath.

What Is Mounjaro?

According to Healthline, Mounjaro is an advanced prescription drug for those battling type 2 diabetes. Delivered via weekly injections, the drug’s groundbreaking approach enhances insulin production while curbing the liver’s sugar output [1].

Its dual-action mimics digestive hormones, offering a beacon of hope for many struggling with blood sugar regulation.

However, alongside Mounjaro’s promise, there are emerging concerns about its safety, similar to issues faced by other drugs like Ozempic and Mounjaro in the past.

As patients navigate the complexities of diabetes management, the importance of transparency and safety in prescription medication remains paramount. This potential for weight loss has caught the attention of those seeking chronic weight loss treatments.

Though approved only for type 2 diabetes, Mounjaro’s clinical trial results for weight loss have led to off-label prescriptions for obesity. Starting at a modest dose and escalating, patients have seen significant results.

A proposed class action MDL targets Eli Lilly for negligence related to Mounjaro’s higher doses of weight loss medication, which were linked to serious gastrointestinal problems. These legal actions underscore the complexity of using a drug for purposes beyond its original approval.

Mounjaro’s ability to delay gastric emptying contributes to reduced appetite and weight loss. However, this same mechanism may also be the culprit behind the severe gastrointestinal issues leading to the current legal battles.

Compared to other weight loss drugs, Mounjaro has similar potential adverse side effects, and ongoing legal actions highlight the risks associated with these medications.

Was Mounjaro Recalled?

Mounjaro was not recalled. The FDA has issued a Drug Safety Communication to highlight the potential risks associated with its use, including a high-level boxed warning related to the risk of gastrointestinal issues.

This action underscores the importance of transparency and the need for drug manufacturers to provide clear and detailed information about potential side effects.

By doing so, the FDA aims to empower patients and healthcare providers to make informed decisions, prioritizing patient safety above all else.

Mounjaro is not approved by the Food and Drug Administration (FDA) for use as a weight loss drug. But because the drug is prescribed along with exercise and a balanced diet, some people may lose weight during their Mounjaro treatment – Amber Watson, PharmD, BCMAS, Assistant Medical Director at NashBio

Side Effects of Mounjaro: Delayed Gastric Emptying

As stated by Healthline, there’s a grave link between Mounjaro and gastrointestinal issues. Mounjaro, functioning as a GLP-1 receptor agonist, is a weight loss drug that delays gastric emptying – a crucial process for normal digestion [2].

Although this weight loss medication might assist in managing blood sugar levels, it could potentially cause prolonged gastric emptying, a forerunner to serious gastroparesis.

Gastroparesis, also known as stomach paralysis, is a crippling condition that goes beyond typical stomach and abdominal pain. It represents a severe gastrointestinal problem where the stomach muscles and nerves are impaired, rendering it unable to perform its crucial function in the digestive system.

The physical pain and psychological torment it inflicts can be intense as patients grapple with symptoms that significantly interfere with their everyday lives.

Clinical studies have backed up this connection, showing that drugs like Mounjaro carry an increased risk of gastrointestinal issues, including gastroparesis.

According to Mana, symptoms of Gastroparesis can include [3]:

  • Severe stomach pain
  • Abdominal pain
  • Gastrointestinal burning
  • Delayed stomach emptying

The plaintiffs in the Mounjaro case reported harrowing experiences, including:

  • Excessive vomiting leads to hospitalizations and even the loss of teeth
  • Severe gastrointestinal burning
  • Persistent stomach inflammation that made eating a nightmare

Such severe gastrointestinal events, which can also be referred to as severe gastrointestinal problems, are not just uncomfortable-they’re life-altering and, in the case of Mounjaro, potentially drug-induced.

How Do You Qualify for a Mounjaro Stomach Paralysis Lawsuit Due to Severe Gastrointestinal Issues?

To qualify for a Mounjaro stomach paralysis lawsuit, you must be able to prove that Mounjaro directly caused your complications. This involves demonstrating that you used the medication as prescribed and subsequently developed severe gastrointestinal issues, such as gastroparesis.

Others who may qualify for the Mounjaro stomach paralysis lawsuit include family members of patients who have suffered significant harm or death due to Mounjaro-related complications and may also be eligible to file claims.

It’s essential to consult with a legal expert to understand the full scope of eligibility and ensure that all necessary documentation and evidence are collected to support your case.

The Status Of The Mounjaro Lawsuit Litigation in Arkansas

Eli Lilly is now facing a battle on multiple fronts, with allegations that they failed to warn patients about the risks associated with Mounjaro. Accusations of neglecting patient safety are at the forefront as individuals grapple with the medical bills and emotional toll of their severe gastrointestinal issues.

The legal proceedings are escalating, with the amalgamation of multiple federal lawsuits into a multidistrict litigation (MDL) supervised by Judge Gene E.K. Pratter. This MDL is designed to simplify pretrial processes for cases explicitly claiming that Mounjaro induced gastroparesis, signifying the seriousness of the allegations against Eli Lilly.

Beyond the MDL, additional lawsuits have mushroomed in New Jersey state court, expanding the scope of the legal battle. Each case represents a person whose life has been turned upside down, highlighting the importance of robust legal oversight and the right to be informed about the medications we take.

Mounjaro Lawsuit Settlement Amounts in Arkansas

Determining the settlement amounts for Mounjaro lawsuits in Arkansas can be complex, as it depends on various factors, including the severity of the plaintiff’s injuries, the extent of medical expenses, lost wages, and the emotional distress suffered.

Typically, settlements aim to compensate for both economic and non-economic damages, ensuring that victims receive adequate financial relief for their suffering.

In similar pharmaceutical lawsuits, settlement amounts have ranged widely, from thousands to millions of dollars, reflecting the diverse impact of the injuries on individuals’ lives.

Plaintiffs in the Mounjaro lawsuit may seek compensation for:

  • Medical bills, including ongoing and future treatment costs.
  • Lost income and diminished earning capacity.
  • Pain and suffering encompass both physical pain and emotional trauma.
  • Loss of quality of life and enjoyment of daily activities.

Filing a Mounjaro Stomach Paralysis Lawsuit in Arkansas

For those contemplating a Mounjaro lawsuit, the journey ahead starts with securing appropriate legal representation. Lawyers specialized in product liability, possessing profound knowledge of such cases, are indispensable for maneuvering through the intricate maze of law and pharmaceutical responsibility.

Types of Evidence To Present

When filing a Mounjaro stomach paralysis lawsuit, presenting robust and comprehensive evidence is critical to substantiate your claims.

Here are the primary types of evidence to consider:

  1. Medical Records: Detailed medical documentation showing the diagnosis of gastroparesis or other severe gastrointestinal issues after using Mounjaro. This includes hospital records, doctor’s notes, test results, and treatment plans.
  2. Prescription Information: Proof that you were prescribed Mounjaro, including pharmacy records and dosage instructions, demonstrating that you used the medication as directed by your healthcare provider.
  3. Expert Testimonies: Opinions from medical experts who can link the use of Mounjaro to the development of gastroparesis, providing professional validation of your claims.
  4. Financial Records: Documentation of medical expenses, including bills for hospital stays, treatments, medications, and any other related costs. Records of lost wages and diminished earning capacity due to the condition are also vital.
  5. Photographic Evidence: Visual documentation of the physical effects of gastroparesis, such as weight loss, surgical scars, or other visible symptoms that corroborate the severity of the condition.
  6. Clinical Studies: Research and clinical trial data highlight the risks of gastrointestinal issues associated with Mounjaro, supporting the argument that the drug is linked to severe side effects.

Collecting and organizing this evidence with the help of a legal expert can significantly strengthen your case and increase the likelihood of a favorable outcome in your Mounjaro stomach paralysis lawsuit.

What is the Statute of Limitations for the Mounjaro Lawsuit in Arkansas?

The statute of limitations for the Mounjaro lawsuit in Arkansas is generally three years from the date of injury or the date when the injury was discovered or reasonably should have been discovered.

Related Articles:

See all related dangerous drug lawsuits our attorneys covered so far.

Choose our lawyers

Have you or a loved one suffered from the adverse side effects caused by defective medication?

Get Your Free Consultation From Our Arkansas Lawyers

The Schmidt & Clark, LLP law firm is here to support you during these challenging times. If you or a loved one has suffered from gastrointestinal disorders due to weight loss drugs like Mounjaro, don’t hesitate to reach out to us.

Our team has extensive experience in handling such cases and will guide you through the legal process. We will provide clarity regarding your rights and assess your eligibility for a lawsuit related to these complications.

Receive a free case evaluation, and remember, we only charge fees if we successfully win your case. You can trust that our commitment to your case is as strong as if you were part of our own family. Contact us today for a comprehensive review of your concerns.



Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.